Evidence for avoiding the use of beta-blockers as first line therapy in hypertension;Les bêtabloquants sont-ils encore des médicaments de premier choix pour le traitement de l'hypertension artérielle non compliquée?

Revue Medicale de Liege

Volumn 62, Issue 5-6, 2007, Pages 254-257

  Krzesinski, J M ^a,b   Saint Remy, A ^b  

^a ULg ^*

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Antihypertensive drugs; Arterial hypertension; Beta blockers; Cardiovascular risk

Indexed keywords

AMLODIPINE; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOSARTAN; METOPROLOL; NEBIVOLOL; PERINDOPRIL; PLACEBO;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; META ANALYSIS; MORTALITY; PRIMARY MEDICAL CARE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; HYPERTENSION;

EID: 35548959290     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Krzesinski J-M. - Actualisation de la prise en charge de l'hypertension artérielle. Rev Med Liège, 1999, 54, 683-687.
2. Guidelines Committee. - 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003, 21, 1011-1053.
3. Blood pressure lowering treatment trialists' collaboration. - Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet, 2003, 362, 1527-1535.
4. Traitement initial de l'hypertension : état de la question. Folia Pharmacotherapeutica, 2004, 31, 28-32.
5. http://www.nice.org.uk/CG034NICEguideline. - Les nouveaux antihypertenseurs sont plus intéressants en terme de prévention du risque cardio-vasculaire que les «anciens» comprenant bêta-bloquants et diurétiques.
6. Khan N, McAlister F. - Re-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysis. CMAJ, 2006, 174, 1737-1742.
7. Dahlöf B, Sever P, Poulter N et al. - Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial. Lancet, 2005, 366, 895-906.
8. Bradley HA, Wiysonge CS, Volmink JA, et al. - How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens, 2006, 24, 2131-2141.
9. Carlberg B, Samuelsson O, Lindholm LH. - Atenolol in hypertension : is it a wise choice? Lancet, 2004, 364, 1684-1689.
10. Wysonge CS, Bradley H, Mayosi B et al. - Beta-blockers for hypertension. Cochrane Database of Systematic Reviews, 2007, 1, CD002003.
11. Freemantle N, Cleland J, Young P, ET AL. - Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ, 1999, 318, 1730-1737.
12. Dahlöf B, Devereux R, Kjeldsen S, et al. - Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 2002, 359, 995-1003.
13. Lindholm LH, Carlberg B, Samuelsson O. - Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet, 2005, 366, 1545-1553.
14. Hasford J, Mimram A, Simons W. - A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens, 2002, 16, 569-575.
15. Staessen J.A., Brikenhäger W.H. - Evidence that new antihypertensives are superior to older drugs. Lancet, 2005, 366, 869-871.
16. O'Rourke M for The CAFE investigators, for the Anglo-Scandinavian Cardiac Outcomes (ASCOT) investigators. - Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFÉ) study. Circulation, 2006, 113, 1213-1225.
17. Mancia G, Grassi G, Zanchetti A. - New-onset diabetes and hypertensive drugs. J Hypertens, 2006, 24, 3-10.
18. Stump G, Hamilton M, Sowers J. - Effect of antihypertensive agents on the development of type 2 diabetes mellitus. Mayo Clin Proc, 2006, 81, 796-806.